Proteomics Markets for Research and IVD Applications reflects Kalorama's market estimates, forecasts and competitive analysis of this important are. As part of its coverage, this report includes the following important data:
Proteomics Technologies, including: Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Bioinformatics, and Others, plus Discussion of Companies Commercializing Platforms Enabling Others to Use These Technologies
Applications of Proteomics, including: Research and Biomarker discovery, Drug Discovery and Development, and in Vitro Diagnostics (IVD)
Deals made by Proteomics Companies: Mergers, Partnerships, Investments
Consortia and Alliances in Proteomics
Proteomics Sales by Geographical Region, Worldwide, (North America, Europe, Asia, ROW)
Market Issues and Opportunities, Including Market Drivers for Immunoassays
Market Estimates for Mass Spectrometry in Proteomics and Forecast to 2018
Market Estimates for Chromatography in Proteomics and Forecast to 2018
Market Estimates for Microarrays in Proteomics and Forecast to 2018
Market Estimates for Electrophoresis in Proteomics and Forecast to 2018
Market Estimates for Immunoassays in Proteomics and Forecast to 2018
Market Estimates for IVD Applications of Proteomics
Market Estimates for Research Applications of Proteomics
Extensive Profiles of Companies
Product and Service Market Opportunity for Proteomics
The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.
Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies.
Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.
Companies profiled in this report include:
AB SCIEX (A Danaher Corporation Company)
ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
Agilent Technologies Inc.
Arbor Vita Corporation
ArcDia International Oy Ltd
Avant Diagnostics, Inc.
AYOXXA Biosystems GmbH
Beckman Coulter, Inc.
(Subsidiary of Danaher Corporation)
Becton, Dickinson and Company (BD)
BG Medicine, Inc.
Bio-Rad Laboratories, Inc.
Cambridge Protein Arrays Ltd.
caprotec bioanalytics GmbH
CardioGenics Holdings, Inc.
CD Diagnostics, Inc.
Chromsystems Instruments & Chemicals GmbH
Clearbridge BioLoc Pte Ltd.
Courtagen Life Sciences, Inc.
Crescendo Bioscience (Subsidiary of Myriad Genetics)
Dasit Group – Focusing on
Dualsystems Biotech AG
GE Healthcare Life Sciences
Geneva Bioinformatics (GeneBio) SA
Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
Integrated Diagnostics, Inc.
Intuitive Biosciences, Inc.
LEAP Technologies, Inc.
Life Technologies Corporation
LSI Medience Corporation
Matrix Science Limited
MBio Diagnostics, Inc.
Rigaku Reagents, Inc.
Sera Prognostics, Inc.
Siemens Healthcare Diagnostics
SISCAPA Assay Technologies, Inc.
SpOtOn Clinical Diagnostics Limited
SQI Diagnostics Inc.
Syngene (Division of Synoptics Ltd)
T2 Biosystems, Inc.
Tecan Group AG
The Binding Site Group Ltd.
Theranostics Health Inc.
Thermo Fisher Scientific, Inc.
Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
Download the full report: https://www.reportbuyer.com/product/2416369/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48